Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,011 | 38 | 91.0% |
| Education | $99.99 | 1 | 9.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $198.76 | 2 | $0 (2022) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $184.45 | 2 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $146.54 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $114.20 | 6 | $0 (2024) |
| Incyte Corporation | $95.07 | 3 | $0 (2022) |
| ABBVIE INC. | $54.63 | 4 | $0 (2024) |
| UCB, Inc. | $50.15 | 1 | $0 (2021) |
| Janssen Biotech, Inc. | $45.07 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $32.89 | 2 | $0 (2023) |
| Lilly USA, LLC | $27.94 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $127.69 | 8 | AstraZeneca Pharmaceuticals LP ($18.01) |
| 2023 | $132.75 | 8 | E.R. Squibb & Sons, L.L.C. ($55.57) |
| 2022 | $543.30 | 15 | PFIZER INC. ($198.76) |
| 2021 | $307.22 | 8 | Ortho Dermatologics, a division of Bausch Health US, LLC ($126.59) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Oncology | ||||||
| 03/26/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.98 | General |
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Respiratory | ||||||
| 03/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Immunology | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: CNS | ||||||
| 02/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/05/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Immunology | ||||||
| 12/12/2023 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 GraftGuide, Kerecis Omega3 SurgiClose | Food and Beverage | Cash or cash equivalent | $21.07 | General |
| Category: Wound Care | ||||||
| 08/16/2023 | Sun Pharmaceutical Industries Inc. | Absorica LD (Drug), Winlevi | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Dermatology | ||||||
| 08/03/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: ETONOGESTREL | ||||||
| 08/01/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| Category: Immunology | ||||||
| 06/10/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.91 | General |
| Category: Immunology | ||||||
| 06/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Immunology | ||||||
| 04/06/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $13.48 | General |
| 03/08/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Dermatology | ||||||
| 12/08/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: Immunology | ||||||
| 12/07/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.01 | General |
| Category: Dermatology | ||||||
| 11/30/2022 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: DERMATOLOGY | ||||||
| 11/10/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Dermatology | ||||||
| 10/04/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.56 | General |
| Category: Immunology | ||||||
| 06/27/2022 | Sun Pharmaceutical Industries Inc. | — | Education | In-kind items and services | $99.99 | General |
| 06/25/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.66 | General |
| Category: Dermatology | ||||||
| 06/04/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $99.38 | General |
| Category: Inflammation & Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 577 | 946 | $183,289 | $38,678 |
| 2022 | 15 | 792 | 1,425 | $241,121 | $52,609 |
| 2021 | 14 | 758 | 1,301 | $232,528 | $48,399 |
| 2020 | 6 | 199 | 363 | $51,403 | $10,864 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 142 | $31,666 | $6,645 | 21.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 76 | 90 | $30,060 | $5,571 | 18.5% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 12 | 19 | $13,205 | $5,328 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 77 | $25,102 | $5,300 | 21.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 98 | 122 | $24,034 | $3,691 | 15.4% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 12 | 16 | $9,840 | $2,489 | 25.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 35 | 38 | $11,362 | $2,279 | 20.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 18 | 19 | $8,423 | $1,856 | 22.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $8,398 | $1,437 | 17.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 69 | 348 | $5,916 | $1,415 | 23.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $4,512 | $925.87 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,401 | $881.77 | 16.3% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 14 | 14 | $3,738 | $637.28 | 17.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $1,632 | $220.70 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 153 | 207 | $46,161 | $10,587 | 22.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 97 | 113 | $37,742 | $7,341 | 19.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 15 | 23 | $15,985 | $7,008 | 43.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 135 | 167 | $32,899 | $5,275 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 61 | $19,886 | $4,010 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 54 | 54 | $17,442 | $3,298 | 18.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 61 | 63 | $18,837 | $3,253 | 17.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 22 | 26 | $11,882 | $2,750 | 23.1% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2022 | 15 | 17 | $10,455 | $2,738 | 26.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 99 | 484 | $8,228 | $2,197 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $7,856 | $1,455 | 18.5% |
About Jenna Mazour, APRN,CNP
Jenna Mazour, APRN,CNP is a Family healthcare provider based in Detroit Lakes, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1043661978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jenna Mazour, APRN,CNP has received a total of $1,111 in payments from pharmaceutical and medical device companies, with $127.69 received in 2024. These payments were reported across 39 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,011).
As a Medicare-enrolled provider, Mazour has provided services to 2,326 Medicare beneficiaries, totaling 4,035 services with total Medicare billing of $150,550. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Detroit Lakes, MN
- Active Since 06/22/2016
- Last Updated 04/09/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1043661978
Products in Payments
- CIBINQO (Drug) $198.76
- DUOBRII (Drug) $126.59
- Sotyktu (Drug) $100.72
- OPZELURA (Drug) $95.07
- JUBLIA (Drug) $57.86
- SKYRIZI (Biological) $54.63
- Cimzia (Drug) $50.15
- DUPIXENT (Biological) $36.52
- TREMFYA (Drug) $29.00
- TALTZ (Drug) $27.94
- ILUMYA (Biological) $26.00
- Kerecis Omega3 SurgiClose (Device) $21.07
- Absorica LD (Drug) $20.55
- COSENTYX (Biological) $19.95
- AIRSUPRA (Drug) $18.01
- AMELUZ (Drug) $17.63
- SINUVA (Drug) $16.19
- ERLEADA (Drug) $16.07
- CYLTEZO (Biological) $13.47
- COSENTYX (Drug) $12.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.